首页 > 产品 > Active Pharmaceutical Ingredient

Milbemycin oxime

产品编号: DCAPI1436
Milbemycin oxime
结构式
129496-10-2
此产品仅供科研所需，我们不出售给病人
​我们将匹配市场上最好的价格给您
Email：order@dcbio.cn
免费咨询电话：4008862077
询盘
我们的合作伙伴:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
中国地区超过5000个高品质化合物库存
应用领域
Milbemycin oxime is a semi-synthetic macrocyclic lactone prepared by the oxidation and oximation of a mixture of two natural products, milbemycin A3 and A4 (in ~70: 30 ratio). Moxidectin oxime, marketed as Interceptor, is used therapeutically for the prev
化学性质生物活性化合物的使用COA & MSDS相关产品产品说明书
Cas No.: 129496-10-2
名称:
别名:
SMILES: O=C1[C@@]([C@@]2(O)[C@@](OC/C2=CC=C[C@H](C)C/C(C)=C/C[C@@]3([H])O[C@]4(O[C@H](CC)[C@@H](C)CC4)C[C@@](C3)([H])O1)([H])/C5=N/O)(C=C5C)[H].O=C6[C@@]([C@@]7(O)[C@@](/C8=NO)(OC/C7=CC=C[C@H](C)C/C(C)=C/C[C@@]9([H])O[C@@](O[C@@H]%10CC)(CC[C@@H]%10C)C[C@@](C9)([H
分子式: C63H88N2O14
分子量: 1097.3778
纯度:
保存条件: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Description:
In Vivo:
In Vitro:
References: For the detailed information of Milbemycin, the solubility of Milbemycin in water, the solubility of Milbemycin in DMSO, the solubility of Milbemycin in PBS buffer, the animal experiment（test） (test) of Milbemycin, the cell expriment (test) of Milbemycin, the in vivo, in vitro and clinical trial test of Milbemycin, the EC50, IC50,and Affinity of Milbemycin,, please contact DC Chemicals.
Kinase Assay:
Cell Assay:
Animal Administration:
References:
MSDS
COA
LOT NO. DOWNLOAD
2018-0101
产品编号 产品名称 应用领域
DCAPI1560 Sitagliptin phosphate Sitagliptin phosphate, an orally active agent, potently inhibits CD26 (DPP-4) with an IC50 of 19 nM. Sitagliptin performs a direct, novel action in order to stimulate GLP-1 secretion by the intestinal L cell through a DPP-4-independent, protein kinase A-
DCAPI1552 streptomycin streptomycin
DCAPI1520 S-adenosyl-L-methionine S-adenosyl-L-methionine
DCAPI1436 Milbemycin oxime Milbemycin oxime is a semi-synthetic macrocyclic lactone prepared by the oxidation and oximation of a mixture of two natural products, milbemycin A3 and A4 (in ~70: 30 ratio). Moxidectin oxime, marketed as Interceptor, is used therapeutically for the prev
DCAPI1425 Anastrozole Anastrozole is known to inhibit the CYP19 enzyme (aromatase, IC50 = 15 nM) that converts androgens to estrogens. Anastrozole has been seen to reversibly bind to the CYP19 enzyme through competitive inhibition.
DCAPI1398 Disulfiram (Antabuse) Disulfiram (Antabuse)
DCAPI1393 Nedaplatin (Aqupla) Nedaplatin (Aqupla) is a derivative of cisplatin for inhibition of tumor colony forming units with IC50 of 28.5 μg/mL.
DCAPI1391 Ranolazine (Ranexa) Ranolazine (Ranexa)
DCAPI1374 Cyclovirobuxin D(Bebuxine) Cyclovirobuxin D(Bebuxine)
DCAPI1231 Salinomycin (Procoxacin) For the detailed information of Salinomycin (Procoxacin), the solubility of Salinomycin (Procoxacin) in water, the solubility of Salinomycin (Procoxacin) in DMSO, the solubility of Salinomycin (Procoxacin) in PBS buffer, the animal experiment（test） (test)
​ 免费咨询电话：4008862077
​ QQ：1026657369
​ 邮箱：order@dcbio.cn
我们所有的产品仅供研究所需，严禁用于人体和其他目的
站点地图|隐私政策Copyright © 2018-2020 All Rights Reserved. 技术支持:库价软件